↓ Skip to main content

Advances in Fecal Tests for Colorectal Cancer Screening

Overview of attention for article published in Current Treatment Options in Gastroenterology, January 2016
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
88 Mendeley
Title
Advances in Fecal Tests for Colorectal Cancer Screening
Published in
Current Treatment Options in Gastroenterology, January 2016
DOI 10.1007/s11938-016-0076-0
Pubmed ID
Authors

Eline H. Schreuders, Esmée J. Grobbee, Manon C. W. Spaander, Ernst J. Kuipers

Abstract

Colorectal cancer (CRC) forms an important public health problem, especially in developed countries. CRC screening tests can be used to identify asymptomatic individuals with CRC precursors and (early) cancer. Removal of these lesions reduces CRC incidence and prevents CRC-related mortality. There are a range of screening tests available, each with advantages and disadvantages. Stool screening tests can broadly be divided into fecal occult blood tests (FOBTs) and molecular biomarker test, such as DNA/RNA marker tests, protein markers, and fecal microbiome marker tests. Guaiac fecal occult blood tests (gFOBT) have been demonstrated in large randomized screening trials to reduce CRC mortality. Fecal immunochemical tests (FIT) have superior adherence, usability, and accuracy as compared to gFOBT. Advantage of the use of quantitative FITs in CRC screening programs is the cut-off level that can be adjusted. Molecular biomarker DNA tests have shown to detect significantly more cancers than FIT. By combining biomarker DNA tests with FIT, sensitivity for advanced adenomas can be increased significantly. However, it has lower specificity thus demands more colonoscopy resources, is more cumbersome, and costly. The adherence has not been assessed in population screening trials. For these reasons, FIT is therefore at present regarded as the preferred method of non-invasive CRC screening. This chapter will review the current status of fecal test-based CRC screening.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 88 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 20%
Researcher 11 13%
Student > Ph. D. Student 9 10%
Student > Bachelor 8 9%
Student > Postgraduate 6 7%
Other 17 19%
Unknown 19 22%
Readers by discipline Count As %
Medicine and Dentistry 31 35%
Biochemistry, Genetics and Molecular Biology 13 15%
Agricultural and Biological Sciences 7 8%
Nursing and Health Professions 4 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 10 11%
Unknown 21 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 January 2016.
All research outputs
#20,303,950
of 22,842,950 outputs
Outputs from Current Treatment Options in Gastroenterology
#241
of 267 outputs
Outputs of similar age
#333,204
of 396,346 outputs
Outputs of similar age from Current Treatment Options in Gastroenterology
#7
of 7 outputs
Altmetric has tracked 22,842,950 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 267 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 396,346 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one.